{ }
Crispr Therapeutics Ag (CRSP) is currently rated weak across all terms, with a buy recommendation near $35.21 targeting $43.04, and a stop loss at $35.11. A short position is advised near $43.04, targeting $35.21, with a stop loss at $43.16. If CRSP breaks above $43.04, a buy signal emerges with a target of $52.41.
UBS Group AG (NYSE: UBS) has received neutral ratings across near, mid, and long-term forecasts, with a current price of 29.61. Trading strategies suggest buying near 31.4 with a target of 33.14 and a stop loss at 31.31, while shorting near 33.14 targets 31.4 with a stop loss at 33.24. For swing and day trading, buy signals are indicated if prices break above 31.99 and 32.09, respectively, with corresponding stop losses set to manage risk.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.